| # | Drug | Count |
|---|---|---|
| 0 | BORTEZOMIB | 7 |
| 1 | DARATUMUMAB | 7 |
| 2 | DEXAMETHASONE | 7 |
| 3 | DEXAMETHASONE 1.5 MG | 7 |
| 4 | PREDNISONE | 2 |
| 5 | RISANKIZUMAB-RZAA | 2 |
| 6 | UPADACITINIB | 2 |
| 7 | AZATHIOPRINE | 1 |
| 8 | IMIQUIMOD | 1 |
| 9 | SIBEPRENLIMAB | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SIBEPRENLIMAB | 1 | 0.0015 |
| 1 | IMIQUIMOD | 1 | 0.0004 |
| 2 | BORTEZOMIB | 7 | 0.0001 |
| 3 | DEXAMETHASONE 1.5 MG | 7 | 0.0000 |
| 4 | UPADACITINIB | 2 | 0.0000 |
| 5 | DEXAMETHASONE | 7 | 0.0000 |
| 6 | VEDOLIZUMAB | 1 | 0.0000 |
| 7 | AZATHIOPRINE | 1 | 0.0000 |
| 8 | PREDNISONE | 2 | 0.0000 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 9 |
| 1 | CD38-directed Cytolytic Antibody [EPC] | 7 |
| 2 | Proteasome Inhibitor [EPC] | 7 |
| 3 | Interleukin-23 Antagonist [EPC] | 2 |
| 4 | Janus Kinase Inhibitor [EPC] | 2 |
| 5 | Integrin Receptor Antagonist [EPC] | 1 |
| 6 | Purine Antimetabolite [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD38-directed Cytolytic Antibody [EPC] | 7 | 0.0012 |
| 1 | Proteasome Inhibitor [EPC] | 7 | 0.0001 |
| 2 | Interleukin-23 Antagonist [EPC] | 2 | 0.0000 |
| 3 | Janus Kinase Inhibitor [EPC] | 2 | 0.0000 |
| 4 | Integrin Receptor Antagonist [EPC] | 1 | 0.0000 |
| 5 | Purine Antimetabolite [EPC] | 1 | 0.0000 |
| 6 | Corticosteroid [EPC] | 9 | 0.0000 |